Sertraline improves the somatic and psychological symptoms of the climacteric syndrome

References

• Utian WH. The normal menopause transition ovarian function, therapy oriented definition of menopause and climacteric. Exp Gerontol 1994;29:245–51
   PubMed Web of Science ®Google Scholar
• McKinlay SM. The normal menopause transition overview. Maturitas 1996;2:137–45
   Web of Science ®Google Scholar
• Heinemann K, Ruebig A, Potthoff P, . The Menopause Rating Scale (MRS) scale: A methodological review. Health Quality Life Outcomes 2004;2:45–52
   PubMedGoogle Scholar
• Palacios S, Ferrer-Barriendo J, Parrillac JJ, . Calidad de vida relacionada con la salud en la mujer española durante la perimenopausia y posmenopausia. Desarrollo y validación de la Escala Cervantes. Med Clin (Barc) 2004;122:205–11
   PubMed Web of Science ®Google Scholar
• Blumel JE, Binfa L, Gramegna G, Tacla X, Aracena B, Cumsille M. Efecto del climaterio en la calidad de vida. Rev Chil Obstet Ginecol 1998;63:437–45
   Google Scholar
• Blumel JE, Castelo-Branco C, Binfa L, . Quality of life after the menopause: a population study. Maturitas 2000;34:17–23
   PubMed Web of Science ®Google Scholar
• Blumel JE, Castelo-Branco C, Cancelo MJ, . Relationship between psychological problems and vasomotor symptoms during climacteric. Maturitas 2004;49:205–10
   PubMed Web of Science ®Google Scholar
• Aedo S, Porcile A, Irribarra C. Calidad de vida relacionada con el climaterio en una población chilena de mujeres saludables. Rev Chil Obstet Ginecol 2006;71:402–6
   Google Scholar
• Fredman MA. Quality of life and menopause: the role of estrogen. J Women´s Health 2002;11:703–18
   Web of Science ®Google Scholar
• Hlatky M, Boothroyd D, Vittinghoff E, Sharp P, Whooley M. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy. Results from the Heart and Estrogen/progestin Replacement Study (HERS) trial. JAMA 2002;287:591–7
   PubMed Web of Science ®Google Scholar
• Chedraui P, Blumel J, Baron G, . Impaired quality of life among middle aged women: A multicentre Latin American study. Maturitas 2008;61:323–9
   PubMed Web of Science ®Google Scholar
• Porcile A, Aedo S, Hernández Y. Fundamentos del uso de estrógenos en dosis bajas con progestina periódica en TRH oral para mujeres postmenopáusicas. Rev Chil Obstet Ginecol 2003;68: 430–8
   Google Scholar
• Aedo S, Schiattino I, Cavada G, Porcile A. Quality of life in climacteric Chilean women treated with low-dose estrogen. Maturitas 2008;61:248–51
   PubMed Web of Science ®Google Scholar
• Porcile A, Martínez E, Venegas E. Esquema terapéutico con etinil estradiol y medroxiprogesterona acetato en el climaterio. Rev Chil Obstet Ginecol 1987;52:107–13
   Google Scholar
• Heinemann LAJ, Dominh T, Strelow F, Gerbsch S, Schnitker J, Schneider HPG. The menopause rating scale (MRS) as outcome measure for hormone treatment? A validation study. Health Quality Life Outcomes 2004;2:67–73
   PubMedGoogle Scholar
• Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxy-progesterone acetate. Women's Health, Osteoporosis, Progestin, Estrogen Study (HOPE). Fertil Steril 2001;75:1065–79
   PubMed Web of Science ®Google Scholar
• Rebar RW, Trabal J, Mortola J. Low-dose esterified estrogens (0.3 mg/day): long-term and short-term effects on menopausal symptoms and quality of life in postmenopausal women. Climacteric 2000;3:176–82
   PubMedGoogle Scholar
• Gambacciani M, Ciaponi M, Cappagli B, . Effects of low-dose continuous combined estradiol and nor-etisterone acetate on menopausal quality of life in early postmenopausal women. Maturitas 2003;44:157–63
   PubMed Web of Science ®Google Scholar
• Haines CJ, Yim SF, Chung TKH, . A prospective, randomized, placebo-controlled study of the dose effect of oral oestradiol on menopausal symptoms, psychological well being, and quality of life in postmenopausal Chinese women. Maturitas 2003;44: 207–14
   PubMed Web of Science ®Google Scholar
• Hulley S, Grady D, Bush T, . Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280: 605–13
   PubMed Web of Science ®Google Scholar
• Grady D, Herrington D, Bittner V, ; HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002;288:49–57
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, . Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–33
   PubMed Web of Science ®Google Scholar
• Ross RK, Paganini-Hill A, Wan PC, Pike MC. Effect of hormone replacement therapy on breast cancer: estrogen versus estrogen plus progestin. J Natl Cancer Inst 2000;92:328–32
   PubMed Web of Science ®Google Scholar
• Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton LA, Hoover R. Menopausal estrogen and estrogen–progestin replacement therapy and breast cancer risk. JAMA 2000;283:485–91
   PubMed Web of Science ®Google Scholar
• Berendsen H. The role of serotonin in hot flushes. Maturitas 2000;36:155–64
   PubMed Web of Science ®Google Scholar
• Veiga S, García-Segura L, Azcoitia I. Propiedades neuroprotectoras de los esteroides sexuales y neuroesteroides. Rev Neurol 2004; 39:1043–51
   PubMed Web of Science ®Google Scholar
• Shanfelt T, Barton D, Adjei A, Lopronzi CL. Pathophysiology and treatment of hot flushes. Mayo Clinic Proc 2002;77:1207–18
   PubMed Web of Science ®Google Scholar
• Amin Z, Canli T, Epperson C. Effect of estrogen–serotonin interactions on mood and cognition. Behaviorial Cognitive Neurosci Rev 2005;4:43–58
   PubMedGoogle Scholar
• Rybaczyk L, Bashaw M, Pathak D, Moody S, Gilders R, Holzschu D. An overlooked connection: serotonergic mediation of estrogen-related and pathology. BMC Women´s Health 2005; 5:12
   PubMedGoogle Scholar
• Kendall DA, Stancel GM, Enna SJ. The influence of sex hormones on antidepressant induced alterations in neurotransmitter receptor binding. J Neurosci 1982;2:354–60
   PubMed Web of Science ®Google Scholar
• Biegon A, McEwen BS. Modulation by estradiol of serotonin receptors in brain. J Neurosci 1982;2:199–205
   PubMed Web of Science ®Google Scholar
• Biegon A, Reches A, Snyder L, McEwen BS. Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sci 1983;32:2015–21
   PubMed Web of Science ®Google Scholar
• Trott EA, Largoza M, Hansen KA. An open trial of sertraline for menopausal hot flushes: potential involvement of serotonin in vasomotor instability. Del Med J 1997;69:481–2
   PubMedGoogle Scholar
• Roth AJ, Scher HI. Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostate cancer. Psychooncology 1998;7:129–32
   PubMed Web of Science ®Google Scholar
• Gordon P, Kerwin J, Boesen K, Pharm D, Senf J. Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population. Menopause 2006;13:568–75
   PubMed Web of Science ®Google Scholar
• Loprinzi C, Barton D, Rummans T. Newer antidepressants inhibit hot flashes. Menopause 2006;13:546–8
   PubMed Web of Science ®Google Scholar
• Kimmick GG, Lovato J, Mcquellon R, Robinson E, Muss H. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen. Breast J 2006; 12:114–22
   PubMed Web of Science ®Google Scholar
• Gottlieb N. Nonhormonal agents show promise against hot flashes. J Natl Inst 2000;92:1118–20
   PubMed Web of Science ®Google Scholar
• Stearns V, Loprinzi C. New therapeutic approaches for hot flashes in women. J Support Oncol 2003;1:11–21
   PubMedGoogle Scholar
• Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4: 561–71
   PubMed Web of Science ®Google Scholar
• Gonzales GF, Carillo C. Blood serotonin levels in postmenopausal women: effects of age and serum estradiol levels. Maturitas 1993;17:23–9
   PubMed Web of Science ®Google Scholar
• Blum I, Vered Y, Lifshitz A, . The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women. Isr J Med Sci 1996;32:1158–62
   PubMedGoogle Scholar
• Halbreich U, Rojanski N, Palter S, Tworek H, Hissin P, Wang K. Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 1995;37:434–41
   PubMed Web of Science ®Google Scholar
• Lippert TH, Filshie M, Mueck AO, Seeger H, Zwirner M. Urinary 5-hydroxyindole acetic acid excretion after estradiol treatment of menopausal women. Maturitas 1996;24:37–41
   PubMed Web of Science ®Google Scholar
• Fink G, Summer BEH. Oestrogen and mental state. Nature 1996;383:306
   PubMed Web of Science ®Google Scholar
• Biegon A. Effects of steroid hormones on the serotonergic system. Whitaker-Azmitia PM, Peroutka SJ. The Neuro-pharmacology of Serotonin. ANYAS 1990:427–34
   Google Scholar
• Biegon A, Grinspoon A, Blumenfeld B, Bleich A, Apter A, Mester R. Increased serotonin 5-HT2 receptor binding on blood platelets of suicidal men. Psycho-phamacology 1990;100: 165–7
   PubMed Web of Science ®Google Scholar
• Gudelski G, Koenig J, Meltzer H. Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Neuropharmacology 1986;25:1307–13
   PubMed Web of Science ®Google Scholar
• Mazzola-Pomietto P, Aulakh C, Wozniak K, Hill J, Murphy D. Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors. Psychopharmacology 1995;117: 193–9
   PubMed Web of Science ®Google Scholar
• Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo controlled trial. Arch Gen Psychiatry 2001;58:529–34
   PubMed Web of Science ®Google Scholar
• Schmidt PJ, Nieman L, Danaceau MA, . Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 2002;183:414–20
   Web of Science ®Google Scholar
• Sherwin B. Estrogen and cognitive functioning in surgically menopausal women. ANYAS 1990;592:474–5
   Web of Science ®Google Scholar
• Zandi PP, Carlson MC, Plassman BL, . Cache County Memory Study Investigators. Hormone replacement therapy and incidence of Alzheimer disease in older women: The Cache County Study. JAMA 2002;288:2123–9
   PubMed Web of Science ®Google Scholar
• Hogervorst E, Williams J, Budge M, Riedel W, Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 2000;101:485–12
   PubMed Web of Science ®Google Scholar
• Le Blanc ES, Janowsky J, Chan BK, Nelson HD. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 2001;285:1489–99
   PubMed Web of Science ®Google Scholar
• Rice K, Morse C. Measuring cognition in menopause research: a review of test use. Climacteric 2003;6:2–22
   PubMed Web of Science ®Google Scholar
• Pecins-Thompson M, Brown NA, Kohama SG, Bethea CL. Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. J Neurosci 1996;16:7021–9
   PubMed Web of Science ®Google Scholar
• Pecins-Thompson M, Brown NA, Bethea CL. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Res Mol Brain Res 1998;53: 120–9
   PubMedGoogle Scholar
• Nelson H, Vesco K, Haney E, . Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 2006;295:2057–71
   PubMed Web of Science ®Google Scholar
• Edwards J, Anderson I. Systematic review and guide to selection of selective serotonin reuptake inhibitors. Drugs 1999;57: 507–33
   PubMed Web of Science ®Google Scholar